Assignee
VASTHERA CO LTD
KR·2 granted patents·6 pending applications·1 citations·filing 2017–2025
Top patents by PatentIndex Score
8 records- 0176US10588910B2Pharmaceutical composition comprising epidithiodioxopiperazine compound or derivative thereof, or pharmaceutically acceptable salt thereof, for preventing or treating pulmonary hypertensionVASTHERA CO LTD·Filed 2017·Granted Mar 17, 2020·1 cites·8 claims
- 0266US2025345343A1Pharmaceutical composition for prevention or treatment of solid cancer comprising epidithiodioxopiperazine derivative or pharmaceutically acceptable salt thereofVASTHERA CO LTD·Filed 2025·Application pending·0 cites
- 0358US2026008784A1Compounds, pharmaceutical compositions containing them and their medical use for the treatment or prevention of vascular diseasesVASTHERA CO LTD·Filed 2023·Application pending·0 cites
- 0457US10450327B2Epidithiodioxopiperazine compound or its derivatives, and the use thereofVASTHERA CO LTD·Filed 2018·Granted Oct 22, 2019·0 cites·8 claims
- 0555US2022323453A1Pharmaceutical composition for prevention or treatment of solid cancer comprising epidithiodioxopiperazine derivative or pharmaceutically acceptable salt thereofVASTHERA CO LTD·Filed 2020·Application pending·0 cites
- 0655US2025214951A13-phenylisoxazole derivative, and pharmaceutical composition for preventing or treating eye disease, containing same as active ingredientVASTHERA CO LTD·Filed 2023·Application pending·0 cites
- 0752US2022202743A1Pharmaceutical composition for preventing or treating degenerative brain disease using autophagy activationVASTHERA CO LTD·Filed 2020·Application pending·0 cites
- 0843US2022265579A1Composition for preventing or treating cardio-cerebrovascular disease comprising autophagy activator as active ingredientVASTHERA CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when VASTHERA CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →